some GH pounds and in a hurry Payday loans 100 or even up to
 

FarmavitaR+

regulatory affairs network

  • Increase font size
  • Default font size
  • Decrease font size
Regulatory Affairs Network

This section is about pricing and reimbursment



Advertising of Reimbursed Drugs

E-mail Print PDF

Croatia - Agreement on Ethical Advertising of Reimbursed Drugs

Due to the new Croatian Ordinance on pricing and reimbursement from this year , every MAH who wants to have its products on reimbursement list in Croatia has to sign the so called "Agreement on Ethical Advertising of Drugs". This Agreement is between MAH and HZZO (Croatian Institute for Health Insurance). I attached Croatian version for you info.

Basically, the Agreement strictly defines ways of advertising the products which are on the reimbursement lists toward healthcare professionals and possibility of giving certain presentation gifts to them (the max. value of such present can't be more than 150 €).

The most important article (No.5)  refers to the obligatory payment of the insurance for ethical advertising to the HZZO. The MAH is obliged to pay to the HZZO the amount of 3% of all budget reimbursed by HZZO for MAHs products on the reimbursement list. This amount makes a annual budget for promotion/presentation of medicinal products in the current year and should be paid in 4 equal parts (in Feb, May, Aug and Nov). This amount can be increased at MAHs request. The MAH is also obliged to present to the HZZO all the costs regarding promotion and presentation of medicinal products with corresponding invoices in order to receive the reimbursement of promotion/presentation costs from the HZZO. This should be done 4 times a year.

In case of breach of this Agreement by the MAH, the HZZO can erase its medicinal products from the reimbursement list. HZZO can also end the reimbursement procedure for the mentioned promotion/presentation costs.

The Agreement has been discussed and negotiates with Association of Innovative Medicines Manufacturers, Croatian Branch.

 

 

Pricing and Reimbursement Conference Review

E-mail Print PDF
User Rating: / 1
PoorBest 

Second annual Conference on Pharmaceutical Risk-Sharing  & Value-based Pricing and Reimbursement Models

Bratislava, 15-16 th April 2010

Pricing and ReimbursmentNot being a specialist in the area of Risk-Sharing & Value-based Pricing this event was an excellent introduction for me. Meeting P&R experts from some of the most important pharma companies in the world as well as hearing their detailed presentations was a really good experience.

The event was splendidly organized by Next Level Pharma in Trend Hotel,Bratislava, SK, near the city centre, which was an excellent location. The overall impression was ruined only by a bad weather which did not allow a proper sightseeing of the city and disturbed air traffic which made problems to the return flight of most participants.

Read more...
 

Croatia - Pricing and Reimbursement News

E-mail Print PDF

Enforcement of new pricing and reimbursement ordinance in Croatia

Croatian Institute for Health Insurance (HZZO) has informed all marketing authorization holders that 22nd August 2009 is deadline for adjustment of thier prices with "Low on Medicines" (Narodne Novine 71/07) and with new  "Ordinance about measures for determination of prices of medicines and ways for reporting about wholesale prices" (Narodne Novine no. 60/08).

loan online

Read more...
 

Pricing & Reimbursement

E-mail Print PDF

datamonitor_logo.gif

Pricing & Reimbursement - Seven Major Markets Update

Governments and payers across the seven major markets are implementing cost-cutting initiatives to combat escalating healthcare costs, putting even greater pressure on pharma companies. In addition to the credit crunch, ever fewer novel products are coming to market, contributing to the declining return on investment.

Read more...
 

Pharmaceutical Pricing and Reimbursement

E-mail Print PDF

business-insights-logo.gif

Pharmaceutical Pricing and Reimbursement: Strategies for market access across the US, Europe, Japan

Pharmaceutical Pricing and Reimbursement examines the tactical importance of price optimization throughout the product lifecycle.

Read more...
 


Banner

Join to  Our Regulatory Affairs Network

farmavitar-network

It is Free. Just Click Here !

Sign in with Facebook

Regulatory Network

Members : 630
Content : 261
Web Links : 5
Content View Hits : 826648

Who's Online

We have 95 guests online

Featured Partners

Regulanet - regulatory affairs consortium

regulanet®: Local representation for Global Regulatory Affairs

 

Tarius - Regulatory Intelligence Databases

Farmavita.Net - pharmaceutical lisensing network

Pharmaceutical Licensing and technology transfer

 

Authnetic and secured web site

 

Increase your website traffic with Attracta.com


Featured Event

ecdf-150x150

 

 

 

 

 

 

PMA150x150

 

 

 

 

 

2013_PharmaCI_Banner_150x150

 

 

 

 

 

 

APACMEDAFF13_150x150

 

 

 

 

 

 

BALS136_150x150

Life_Sciences_banner_Farmavita_150x150

INLS03-banner_150x150


Active Groups

Latest Discussion

{captcha}